Catherine Laversuch

Prevention of vascular damage in scleroderma and autoimmune Raynaud's phenomenon: A multicenter, randomized, double‐blind, placebo‐controlled trial of the angiotensin‐converting enzyme inhibitor quinapril

A. Gliddon, Caroline J Doré, C. M. Black et al. · Arthritis & Rheumatism · 2007 · 124 citations

Medicine, Pharmacology, Pharmacotherapy +13

Malignancy in scleroderma patients from south west England: a population-based cohort study

Keith Siau, Catherine Laversuch, Paul Creamer et al. · Rheumatology International · 2010 · 44 citations · Full text

Medicine, Dermatology, Oncology +11

Reduction in heart rate variability in patients with systemic lupus erythematosus.

Catherine Laversuch, Hye–Sun Seo, Hamid Modarres et al. · PubMed · 1997 · 40 citations

Nursing, Cardiology, Physiology +17

Association between age at disease onset of anti-neutrophil cytoplasmic antibody–associated vasculitis and clinical presentation and short-term outcomes

Sara Monti, Anthea Craven, Catherine Klersy et al. · Lara D. Veeken · 2020 · 39 citations · Full text

Life Sciences, Immunology, Pathology +14

CEREBRAL VENOUS THROMBOSIS AND ACQUIRED PROTEIN S DEFICIENCY: AN UNCOMMON CAUSE OF HEADACHE IN SYSTEMIC LUPUS ERYTHEMATOSUS

Catherine Laversuch, Martin M. Brown, Andrew Clifton et al. · Lara D. Veeken · 1995 · 24 citations

Medicine, Nephrology, Neurology +15